Form 4 for VRCA Verrica Pharmaceuticals Inc.
Accepted 2021-12-06 00:00:00 ET · period of report 2021-12-02 · accession 0001209191-21-068031 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-12-06 | 2021-12-02+ | VRCA | Manning Paul B | Dir, 10% | P - Purchase | $9.36 | +50.0K | 8.15M | +0.6% | +$467.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-02 | P | A | 30,023 | $9.45 | 8,129,417 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.335 to $9.64 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (3). (F2) Consists of 7,754,783 shares of common stock held by Mr. Manning and 374,634 shares of common stock held by Mr. Manning jointly with his spouse. |
| 2 | Common | Common Stock | 2021-12-03 | P | A | 19,977 | $9.22 | 8,149,394 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.01 to $9.77 inclusive. (F4) Consists of 7,754,783 shares of common stock held by Mr. Manning and 394,611 shares of common stock held by Mr. Manning jointly with his spouse. |